Table 3. Relation of baseline triglycerides specie level to future adverse cardiovascular outcome adjusting for Framingham risk factors.
Model | TAG48∶1 (n = 424) | TAG48∶2 (n = 424) | TAG48∶3 (n = 402) | TAG50∶3 (n = 424) | TAG50∶4 (n = 423) |
Models adjusting for sex, age, BMI, type 2 diabetes, anti-hypertension treatment, smoking, LDL, HDL and SBP | |||||
Lipid specie as continuous variable | |||||
Per s.d. | 0.78 (0.63–0.98) | 0.79 (0.64–0.98) | 0.81 (0.65–1.00) | 0.79 (0.63–0.98) | 0.79 (0.64–0.98) |
P | 0.031 | 0.034 | 0.049 | 0.036 | 0.033 |
q-value | 0.210 | 0.210 | 0.228 | 0.210 | 0.210 |
Values are odds ratios (95% confidence intervals) for cardiovascular disease from multivariate adjusted binary logistic regressions performed with the Z score of a given triacylglyceride specie obtained after log transformation. BMI, body mass index; HDL, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TAG, triacylglyceride.